2026-10-29 12:38:06 UTC#537342newconfirmedpress release
XENE stock news
XENE stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-01 13:20:01 UTC#398961newconfirmednews
Xenon Pharmaceuticals CEO Ian Mortimer discloses $1.12M purchase of 30,000 common shares
2026-09-23 18:51:34 UTC#357824newconfirmednews
Xenon Pharmaceuticals files NDA for azetukalner in focal-onset seizures; pauses psychiatry program
2026-09-18 17:27:03 UTC#334994newconfirmednews
Xenon Pharmaceuticals downgraded at Deutsche Bank following clinical trial pause
2026-09-18 15:00:46 UTC#334239duplicateconfirmednews
Market Movers: On Holding signs Kylian Mbappé; Xenon halts trial; Netflix downgraded by Wells Fargo
bloombergimportance 0.30trust 0.90On Holding AG +0.40Kylian Mbappé +0.40Xenon Pharmaceuticals Inc. -0.70+2 entities
2026-09-18 13:54:54 UTC#333851newconfirmednews
RBC Capital maintains Outperform rating on Xenon Pharmaceuticals, sets $70 price target
tradingviewimportance 0.40trust 0.70RBC Capital Markets +0.30Xenon Pharmaceuticals Inc. +0.30azetukalner +0.30
2026-09-18 13:32:00 UTC#333714newconfirmednews
Wedbush cuts Xenon Pharmaceuticals (XENE) price target to $55 from $71
2026-09-18 12:34:00 UTC#333327newconfirmednews
Wells Fargo maintains Overweight rating on Xenon Pharmaceuticals (XENE)
2026-09-18 11:48:19 UTC#333103updateconfirmednews
Premarket movers: Xenon Pharmaceuticals drops 25% on trial pause; Netflix falls on Wells Fargo downgrade
cnbcimportance 0.50trust 0.80Netflix, Inc. -0.40Nucor Corporation -0.50Xenon Pharmaceuticals Inc. -0.80+2 entities
2026-09-18 11:32:00 UTC#333029duplicateconfirmednews
Xenon Pharmaceuticals shares drop as azetukalner clinical trial pause overshadows NDA filing
dow_jonesimportance 0.30trust 0.80Xenon Pharmaceuticals Inc. -0.70azetukalner -0.50Deutsche Bank AG 0
2026-09-18 09:01:21 UTC#332284newconfirmednews
Friday premarket stock movers include Xenon Pharmaceuticals (XENE) and Nucor (NUE)
2026-09-17 23:30:15 UTC#330452duplicateconfirmednews
Xenon Pharmaceuticals submits azetukalner NDA for focal seizures, pauses psychiatric study enrollment
quartrimportance 0.30trust 0.60Xenon Pharmaceuticals Inc. +0.10azetukalner +0.10Food and Drug Administration +0.20
2026-09-17 22:58:52 UTC#330382duplicateconfirmednews
Xenon Pharmaceuticals submits azetukalner NDA for focal seizures, pauses psychiatric study enrollment
quartrimportance 0.30trust 0.50Xenon Pharmaceuticals Inc. +0.20Azetukalner +0.20Food and Drug Administration +0.30
2026-09-17 22:05:00 UTC#330262duplicateconfirmednews
Xenon Pharmaceuticals pauses azetukalner depression trial enrollment over safety concerns
2026-09-17 20:41:43 UTC#329970duplicateconfirmednews
Xenon Pharmaceuticals pauses psychiatric trial enrollment due to side effects
2026-09-17 20:34:21 UTC#329917duplicateconfirmednews
Xenon Pharmaceuticals pauses azetukalner psychiatric trial enrollment due to side effects
reutersimportance 0.40trust 0.90Xenon Pharmaceuticals Inc. -0.80azetukalner -0.70U.S. Food and Drug Administration 0
2026-09-17 20:25:56 UTC#329852duplicateconfirmednews
Xenon Pharmaceuticals shares decline following pause in azetukalner depression study enrollment
2026-09-17 20:24:00 UTC#329863duplicateconfirmednews
Xenon Pharmaceuticals pauses azetukalner psychiatric trial enrollment following adverse events
dow_jonesimportance 0.60trust 0.80Xenon Pharmaceuticals Inc. -0.80azetukalner -0.70Food and Drug Administration 0
2026-09-17 20:04:24 UTC#329796duplicateconfirmednews
Xenon Pharmaceuticals Submits Azetukalner NDA for Focal Seizures, Pauses MDD Study Enrollment
financial postimportance 0.40trust 0.80Xenon Pharmaceuticals Inc. +0.40azetukalner +0.50U.S. Food and Drug Administration +0.30+1 entities
2026-09-17 20:01:00 UTC#329723duplicateconfirmednews
Xenon Pharmaceuticals files NDA for azetukalner in focal seizures, pauses psychiatric study enrollments
tradingviewimportance 0.50trust 0.70Xenon Pharmaceuticals Inc. +0.20azetukalner +0.40Food and Drug Administration +0.30